vs
GLOBUS MEDICAL INC（GMED）与TrueBlue, Inc.（TBI）财务数据对比。点击上方公司名可切换其他公司
GLOBUS MEDICAL INC的季度营收约是TrueBlue, Inc.的2.0倍（$826.4M vs $418.2M），GLOBUS MEDICAL INC同比增速更快（25.7% vs 8.3%），GLOBUS MEDICAL INC自由现金流更多（$202.4M vs $-7.5M），过去两年GLOBUS MEDICAL INC的营收复合增速更高（16.7% vs 1.9%）
Globus Medical是总部位于美国宾夕法尼亚州奥杜邦的上市骨科医疗器械企业，专注于相关产品的设计、研发与商业化，助力外科医生为肌肉骨骼系统疾病患者提供治疗方案，促进患者康复。
蓝鸟公司是一家美国巴士制造商，总部位于佐治亚州福瓦尔谷。该公司以生产校车闻名于世，除此之外还生产多种其他类型巴士，包括城市公交巴士、房车，以及流动图书馆、移动警务指挥中心等特种车辆。
GMED vs TBI — 直观对比
营收规模更大
GMED
是对方的2.0倍
$418.2M
营收增速更快
GMED
高出17.4%
8.3%
自由现金流更多
GMED
多$209.9M
$-7.5M
两年增速更快
GMED
近两年复合增速
1.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $826.4M | $418.2M |
| 净利润 | $140.6M | — |
| 毛利率 | 68.4% | 21.5% |
| 营业利润率 | 20.5% | -7.0% |
| 净利率 | 17.0% | — |
| 营收同比 | 25.7% | 8.3% |
| 净利润同比 | 430.4% | — |
| 每股收益（稀释后） | $1.01 | $-1.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GMEDTBI
| Q4 25 | $826.4M | $418.2M | ||
| Q3 25 | $769.0M | $431.3M | ||
| Q2 25 | $745.3M | $396.3M | ||
| Q1 25 | $598.1M | $370.3M | ||
| Q4 24 | $657.3M | $386.0M | ||
| Q3 24 | $625.7M | $382.4M | ||
| Q2 24 | $629.7M | $396.2M | ||
| Q1 24 | $606.7M | $402.9M |
净利润GMEDTBI
| Q4 25 | $140.6M | — | ||
| Q3 25 | $119.0M | $-1.9M | ||
| Q2 25 | $202.8M | $-160.0K | ||
| Q1 25 | $75.5M | $-14.3M | ||
| Q4 24 | $26.5M | — | ||
| Q3 24 | $51.8M | $-7.6M | ||
| Q2 24 | $31.8M | $-104.7M | ||
| Q1 24 | $-7.1M | $-1.7M |
毛利率GMEDTBI
| Q4 25 | 68.4% | 21.5% | ||
| Q3 25 | 67.2% | 22.7% | ||
| Q2 25 | 66.6% | 23.6% | ||
| Q1 25 | 67.3% | 23.3% | ||
| Q4 24 | 59.9% | 26.6% | ||
| Q3 24 | 56.8% | 26.2% | ||
| Q2 24 | 58.7% | 26.4% | ||
| Q1 24 | 60.2% | 24.7% |
营业利润率GMEDTBI
| Q4 25 | 20.5% | -7.0% | ||
| Q3 25 | 17.9% | -0.0% | ||
| Q2 25 | 10.2% | -0.7% | ||
| Q1 25 | 16.2% | -3.8% | ||
| Q4 24 | 9.2% | -2.7% | ||
| Q3 24 | 7.7% | -1.8% | ||
| Q2 24 | 7.9% | -15.1% | ||
| Q1 24 | 1.3% | -3.8% |
净利率GMEDTBI
| Q4 25 | 17.0% | — | ||
| Q3 25 | 15.5% | -0.4% | ||
| Q2 25 | 27.2% | -0.0% | ||
| Q1 25 | 12.6% | -3.9% | ||
| Q4 24 | 4.0% | — | ||
| Q3 24 | 8.3% | -2.0% | ||
| Q2 24 | 5.0% | -26.4% | ||
| Q1 24 | -1.2% | -0.4% |
每股收益（稀释后）GMEDTBI
| Q4 25 | $1.01 | $-1.06 | ||
| Q3 25 | $0.88 | $-0.06 | ||
| Q2 25 | $1.49 | $-0.01 | ||
| Q1 25 | $0.54 | $-0.48 | ||
| Q4 24 | $0.19 | $-0.41 | ||
| Q3 24 | $0.38 | $-0.26 | ||
| Q2 24 | $0.23 | $-3.45 | ||
| Q1 24 | $-0.05 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $557.2M | $24.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $4.6B | $274.6M |
| 总资产 | $5.3B | $638.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GMEDTBI
| Q4 25 | $557.2M | $24.5M | ||
| Q3 25 | $18.8M | $19.9M | ||
| Q2 25 | — | $21.9M | ||
| Q1 25 | — | $23.1M | ||
| Q4 24 | $890.1M | $22.5M | ||
| Q3 24 | $71.9M | $14.5M | ||
| Q2 24 | $82.5M | $26.4M | ||
| Q1 24 | $80.4M | $36.2M |
股东权益GMEDTBI
| Q4 25 | $4.6B | $274.6M | ||
| Q3 25 | $4.4B | $304.3M | ||
| Q2 25 | $4.3B | $305.2M | ||
| Q1 25 | $4.1B | $302.2M | ||
| Q4 24 | $4.2B | $315.4M | ||
| Q3 24 | $4.1B | $327.2M | ||
| Q2 24 | $4.0B | $337.8M | ||
| Q1 24 | $3.9B | $446.4M |
总资产GMEDTBI
| Q4 25 | $5.3B | $638.7M | ||
| Q3 25 | $5.1B | $690.5M | ||
| Q2 25 | $5.0B | $672.8M | ||
| Q1 25 | $4.7B | $692.5M | ||
| Q4 24 | $5.3B | $675.4M | ||
| Q3 24 | $5.1B | $702.4M | ||
| Q2 24 | $5.0B | $723.7M | ||
| Q1 24 | $4.9B | $868.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $248.6M | $-4.4M |
| 自由现金流经营现金流 - 资本支出 | $202.4M | $-7.5M |
| 自由现金流率自由现金流/营收 | 24.5% | -1.8% |
| 资本支出强度资本支出/营收 | 5.6% | 0.7% |
| 现金转化率经营现金流/净利润 | 1.77× | — |
| 过去12个月自由现金流最近4个季度 | $588.8M | $-73.7M |
8季度趋势，按日历期对齐
经营现金流GMEDTBI
| Q4 25 | $248.6M | $-4.4M | ||
| Q3 25 | $249.7M | $-19.8M | ||
| Q2 25 | $77.9M | $-11.8M | ||
| Q1 25 | $177.3M | $-22.1M | ||
| Q4 24 | $210.3M | $6.1M | ||
| Q3 24 | $203.7M | $-7.1M | ||
| Q2 24 | $54.3M | $-1.8M | ||
| Q1 24 | $52.4M | $-14.2M |
自由现金流GMEDTBI
| Q4 25 | $202.4M | $-7.5M | ||
| Q3 25 | $213.9M | $-23.4M | ||
| Q2 25 | $31.3M | $-16.1M | ||
| Q1 25 | $141.2M | $-26.8M | ||
| Q4 24 | $193.2M | $854.0K | ||
| Q3 24 | $161.7M | $-12.7M | ||
| Q2 24 | $26.5M | $-7.7M | ||
| Q1 24 | $23.8M | $-21.6M |
自由现金流率GMEDTBI
| Q4 25 | 24.5% | -1.8% | ||
| Q3 25 | 27.8% | -5.4% | ||
| Q2 25 | 4.2% | -4.0% | ||
| Q1 25 | 23.6% | -7.2% | ||
| Q4 24 | 29.4% | 0.2% | ||
| Q3 24 | 25.8% | -3.3% | ||
| Q2 24 | 4.2% | -2.0% | ||
| Q1 24 | 3.9% | -5.4% |
资本支出强度GMEDTBI
| Q4 25 | 5.6% | 0.7% | ||
| Q3 25 | 4.7% | 0.8% | ||
| Q2 25 | 6.2% | 1.1% | ||
| Q1 25 | 6.0% | 1.3% | ||
| Q4 24 | 2.6% | 1.4% | ||
| Q3 24 | 6.7% | 1.5% | ||
| Q2 24 | 4.4% | 1.5% | ||
| Q1 24 | 4.7% | 1.8% |
现金转化率GMEDTBI
| Q4 25 | 1.77× | — | ||
| Q3 25 | 2.10× | — | ||
| Q2 25 | 0.38× | — | ||
| Q1 25 | 2.35× | — | ||
| Q4 24 | 7.94× | — | ||
| Q3 24 | 3.93× | — | ||
| Q2 24 | 1.71× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GMED
| Other | $391.8M | 47% |
| Nevro Merger Agreement | $293.6M | 36% |
| Enabling Technologies | $141.0M | 17% |
TBI
| People Scout | $187.7M | 45% |
| Other | $175.0M | 42% |
| Healthcare Staffing Professionals Inc. | $55.5M | 13% |
